Monocyte chemoattractant protein-1 gene expression in prostatic hyperplasia and prostate adenocarcinoma.
about
From mice to humans: identification of commonly deregulated genes in mammary cancer via comparative SAGE studies.Defective NKT cell activation by CD1d+ TRAMP prostate tumor cells is corrected by interleukin-12 with α-galactosylceramide.Dissecting the autocrine and paracrine roles of the CCR2-CCL2 axis in tumor survival and angiogenesis.Plasma monocyte chemotactic protein-1 remains elevated after minimally invasive colorectal cancer resection.FSP1+ fibroblasts promote skin carcinogenesis by maintaining MCP-1-mediated macrophage infiltration and chronic inflammation.CCL2 is a potent regulator of prostate cancer cell migration and proliferation.Tumor cells and tumor-associated macrophages: secreted proteins as potential targets for therapy.Role of bone marrow-derived cells in angiogenesis: focus on macrophages and pericytes.Reduced expression of chemokine (C-C motif) ligand-2 (CCL2) in ovarian adenocarcinomaMonocyte chemoattractant protein-1 serum levels in ovarian cancer patients.Inflammatory Responses in a Benign Prostatic Hyperplasia Epithelial Cell Line (BPH-1) Infected with Trichomonas vaginalis.Progression of benign prostatic hyperplasia is associated with pro-inflammatory mediators and chronic activation of prostate-infiltrating lymphocytes.Targeting chemokine (C-C motif) ligand 2 (CCL2) as an example of translation of cancer molecular biology to the clinic.Monocyte chemotactic protein-1 (MCP-1/CCL2) is associated with prostatic growth dysregulation and benign prostatic hyperplasia.Induction of monocyte chemoattractant protein-1 by nicotine in pancreatic ductal adenocarcinoma cells: role of osteopontin.Best of the 2009 AUA Annual Meeting: Highlights from the 2009 Annual Meeting of the American Urological Association, April 25-30, 2009, Chicago, IL.
P2860
Q33208592-5222D034-7EF8-4ACC-BBE6-A8D1FB855A2CQ33622444-2C6E4A54-D189-4376-A9DD-C56BB9913E13Q34141587-921F7680-5045-4311-89D8-5E3256765CC1Q34340961-91A9D071-0B6C-4A68-9526-723E8E1FABCCQ34760652-CCF6219F-D560-46DA-9D17-F9887489B944Q35082684-6F993333-DD18-4DBD-897E-961B83F9E8C3Q35582297-5372B009-5A4E-487F-B12A-0C5930228000Q36284948-7D3A638D-65A6-4027-9AC8-7C8A9A80B1ECQ36615915-C863F5C6-E2BC-4E99-AA5E-AB94C79AB79AQ36640987-479F829E-83CE-4727-AC36-5D8F407C4FBEQ36911891-28A5B05B-818F-45F5-AD78-6086F244F912Q37269077-303D5A8A-DD50-42B3-AD7B-02A783962DA9Q37809345-5D0F938A-9229-42C1-B314-41BBDF2A8C95Q38956732-3928C851-DACB-4536-A096-389CE25CBB7AQ39688172-46CB1323-F2B0-4CA6-B764-EE382EAD6FBFQ51135496-037B61AE-21DF-42D6-A9A7-63F2DD7BFBBF
P2860
Monocyte chemoattractant protein-1 gene expression in prostatic hyperplasia and prostate adenocarcinoma.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Monocyte chemoattractant prote ...... a and prostate adenocarcinoma.
@ast
Monocyte chemoattractant prote ...... a and prostate adenocarcinoma.
@en
type
label
Monocyte chemoattractant prote ...... a and prostate adenocarcinoma.
@ast
Monocyte chemoattractant prote ...... a and prostate adenocarcinoma.
@en
prefLabel
Monocyte chemoattractant prote ...... a and prostate adenocarcinoma.
@ast
Monocyte chemoattractant prote ...... a and prostate adenocarcinoma.
@en
P2093
P2860
P1476
Monocyte chemoattractant prote ...... a and prostate adenocarcinoma.
@en
P2093
Baggiolini M
Kappeler A
Laissue JA
Loetscher P
Mazzucchelli L
Uguccioni M
P2860
P304
P407
P577
1996-08-01T00:00:00Z